We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601988:SSEBank of China Limited Class A Analysis

Data as of 2026-06-03 - not real-time

CN¥5.95

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading comfortably above its 20‑day and 50‑day moving averages, with the 20‑day SMA just nudging higher than the 50‑day SMA, confirming a short‑term bullish bias. Momentum indicators reinforce this view: the RSI sits in the low‑60s, indicating strength without being overbought, and the MACD line remains above its signal, producing a positive histogram. Volume has been on the rise, supporting the price advance, while the 30‑day volatility of roughly 15% is moderate and the beta is exceptionally low, suggesting the share moves largely independently of broader market swings.
Valuation metrics paint a compelling picture of undervaluation: the price‑to‑earnings ratio is about half the industry average and the price‑to‑book is well under one, while a dividend yield near 4% with a payout ratio around 30% signals sustainable income. Fundamental health is mixed – operating cash flow is negative, yet the bank holds a massive cash buffer and benefits from strong government backing, which mitigates concerns over its sizable debt load. Overall, the combination of bullish technicals, attractive valuation, and a solid dividend makes the stock a noteworthy candidate for investors seeking stable returns with limited market risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA crossover and MACD alignment
  • RSI indicating continued momentum
  • Rising volume supporting price strength

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation discount to peers
  • Stable dividend yield with low payout ratio
  • Low beta reducing market‑wide volatility exposure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong government backing and capital adequacy
  • Sustainable dividend policy
  • Consistently low correlation with broader market movements

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin43.26%
P/E Ratio8.0
ROE8.37%
ROA0.69%
P/B Ratio0.7
Op. Cash FlowCN¥-543587008512
Industry P/E16.4

Technical Analysis

TrendBullish
RSI61.3
SupportCN¥5.61
ResistanceCN¥6.05
MA 20CN¥5.81
MA 50CN¥5.76
MA 200CN¥5.60
MACDBullish
VolumeIncreasing
Fear & Greed Index92.73

Valuation

GradeUndervalued
TypeValue
Dividend Yield3.87%

Risk Assessment

Beta0.04
Volatility15.16%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.